Top News

GSK Plans Increase in Antibiotic Production in Singapore

June 30, 2015

GSK will invest in an additional downstream isolation facility for amoxicillin production in Singapore.

Bristol-Myers Squibb Makes Changes in R&D Locations and Focus

June 29, 2015

Bristol-Myers Squibb builds R&D facilities in Massachusetts and San Francisco and discontinues discovery research in virology.

CHMP Recommends 10 Medicines for Approval

June 26, 2015

Enzyme replacement therapies for rare diseases and cancer treatments are recommended for approval.

GSK Sells Two Meningitis Vaccines to Pfizer

June 25, 2015

The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.

European Pharmacopoeia Commission Updates Ph.Eur.

June 23, 2015

The European Pharmacopoeia adopts six new texts and revises 31 monographs in its 152nd session.

Allergan Acquires Kythera for $2.1 Billion

June 18, 2015

Kythera announces that it entered into a definitive agreement to be acquired by Allergan for $2.1 billion.

BIO Stresses Innovation with Name Change

June 17, 2015

The Biotechnology Industry Organization announced a name change to the Biotechnology Innovation Organization, effective in early 2016.

FDA Advisory Panel Backs Amgen's Repatha

June 11, 2015

An advisory panel deemed Amgen’s Repatha (evolocumab) to be safe overall.

FDA Panel Recommends Approval of Praluent

June 10, 2015

An FDA advisory panel voted 13-3 in favor of approval of Sanofi and Regeneron Pharmaceuticals' cholesterol-homeostasis therapy Praluent (alirocumab).

Will New PCSK9 Drugs Affect Overall Drug Spending?

June 09, 2015

As FDA advisory committees meet on two potential PCSK9 inhibitors, Prime Therapeutics analyzes the impact that this class of drugs may have on overall drug spending.